AnaptysBio Inc buy UBS Group AG
Start price
17.03.26
/
50%
€58.00
Target price
17.03.27
€78.28
Performance (%)
-6.24%
Price
15.05.26
€52.62
Summary
This prediction is currently active. With a performance of -6.24%, the BUY prediction by UBS_Group_AG is trending in the wrong direction. This prediction currently runs until 17.03.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| AnaptysBio Inc | -10.358% | -10.358% |
| iShares Core DAX® | -2.111% | -1.094% |
| iShares Nasdaq 100 | 1.081% | 13.125% |
| iShares Nikkei 225® | -2.215% | 7.976% |
| iShares S&P 500 | 1.596% | 7.239% |
Comments by UBS_Group_AG for this prediction
In the thread AnaptysBio Inc diskutieren
AnaptysBio (ANAB) had its price target raised by UBS Group AG from $70.00 to $90.00. They now have a "buy" rating on the stock.
Ratings data for ANAB provided by MarketBeat